BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16503239)

  • 1. Molecular targeted therapy: a strategy of disillusions or optimism?
    Eckhardt S
    J Lab Clin Med; 2006 Mar; 147(3):108-13. PubMed ID: 16503239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV
    Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of signal transduction: epidermal growth factor receptor family, vascular endothelial growth factor family, Kit, platelet-derived growth factor receptor, Ras.
    Erman M
    J BUON; 2007 Sep; 12 Suppl 1():S83-94. PubMed ID: 17935283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of drug inhibition of signalling molecules.
    Sebolt-Leopold JS; English JM
    Nature; 2006 May; 441(7092):457-62. PubMed ID: 16724058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted therapy: for kids, too.
    Corey SJ
    Pediatr Blood Cancer; 2005 Oct; 45(5):623-34. PubMed ID: 15704219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular-targeted therapies: lessons from years of clinical development.
    Rosa DD; Ismael G; Lago LD; Awada A
    Cancer Treat Rev; 2008 Feb; 34(1):61-80. PubMed ID: 17826917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted cancer therapy: promise and reality.
    Klein S; Levitzki A
    Adv Cancer Res; 2007; 97():295-319. PubMed ID: 17419951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development.
    Martínez-Sánchez G; Giuliani A
    J Exp Clin Cancer Res; 2007 Mar; 26(1):39-50. PubMed ID: 17550131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
    Faivre S; Djelloul S; Raymond E
    Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic strategies by modulating oxygen stress in cancer and inflammation.
    Fang J; Seki T; Maeda H
    Adv Drug Deliv Rev; 2009 Apr; 61(4):290-302. PubMed ID: 19249331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted therapies: a new generation of cancer treatments.
    Gerber DE
    Am Fam Physician; 2008 Feb; 77(3):311-9. PubMed ID: 18297955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular-targeted therapy for malignant glioma].
    Yamanaka R
    Brain Nerve; 2009 Feb; 61(2):177-88. PubMed ID: 19235468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR targeting therapies: monoclonal antibodies versus tyrosine kinase inhibitors. Similarities and differences.
    Dassonville O; Bozec A; Fischel JL; Milano G
    Crit Rev Oncol Hematol; 2007 Apr; 62(1):53-61. PubMed ID: 17324578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted cancer therapeutics.
    Hait WN; Hambley TW
    Cancer Res; 2009 Feb; 69(4):1263-7; discussion 1267. PubMed ID: 19208830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of chemotherapeutic drugs in adjuvant programs based on molecular profiles: where do we stand?
    Biganzoli L; Claudino WM; Pestrin M; Pozzessere D; Di Leo A
    Crit Rev Oncol Hematol; 2007 Apr; 62(1):1-8. PubMed ID: 17317203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-molecule and antibody approaches to molecular chemotherapy of primary brain tumors.
    Newton HB
    Curr Opin Investig Drugs; 2007 Dec; 8(12):1009-21. PubMed ID: 18058572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR-targeted anti-cancer drugs in radiotherapy: preclinical evaluation of mechanisms.
    Baumann M; Krause M; Dikomey E; Dittmann K; Dörr W; Kasten-Pisula U; Rodemann HP
    Radiother Oncol; 2007 Jun; 83(3):238-48. PubMed ID: 17502118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New drugs in prostate cancer.
    Armstrong AJ; Carducci MA
    Curr Opin Urol; 2006 May; 16(3):138-45. PubMed ID: 16679849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small cell lung cancer and targeted therapies.
    Blackhall FH; Shepherd FA
    Curr Opin Oncol; 2007 Mar; 19(2):103-8. PubMed ID: 17272981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.